Cancers in young patients in Uyo (Niger-delta region of Nigeria): magnitude of the problem and histopathological prolife

被引:0
作者
Abudu, Emmanuel Kunle [1 ]
Akinbamiz, Oluyinka Samuel [2 ]
机构
[1] Univ Uyo Teaching Hosp, Dept Histopathol, Uyo, Akwa Ibom State, Nigeria
[2] Univ Uyo Teaching Hosp, Dept Family Med, Uyo, Akwa Ibom State, Nigeria
关键词
Cancers; young patients; Uyo; Nigeria;
D O I
10.4081/rt.2016.6124
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancers are thought to be rarer in younger population, but emerging data show an increasing incidence of these diseases. The aim of this study was to evaluate the clinicopathological characteristics of cancer among young patients (>= 30 years) in Uyo, Nigeria. All specimens were collected and reviewed during the period January 2007-December 2012; complete clinicopathological data were also considered. A total of 108 cases of proven cancers were diagnosed (3.4%). accounting for 14.1% of all malignancies. A male:female ratio of 1:3.2 was recorded. Among 0-14-year-old patients, the most common malignancy was embryonal cancer (50.0%). followed by non Hodgkin's lymphoma (18.8%). Carcinoma of the breast and soft tissue sarcoma represent first and second cancers in those patients (40.7% and 13.0% respectively). Carcinoma of uterine cervix and nodal lymphomas were the third and fourth most common cancers respectively (10.2% and 7.4%), significantly higher in the 21-30 years and 0-10 years age groups. Invasive ductal carcinoma, squamous cell carcinoma, Kaposi sarcoma and Hodgkin's lymphoma were the most common histologic types of cancers in breast, uterine cervix, lymph node and soft tissue (79.6%, 90.0%, 44.4%, 50.0% respectively). This study shows that embryonal cancer was the most common malignancy in patients aged 0 to 14. while carcinoma of the breast and soft tissue sarcoma were the two most common cancers in patients from 5 to 30 years-old.
引用
收藏
页数:4
相关论文
共 19 条
  • [1] Abudu EK, 2014, WORLD J BIOMED RES, V1, P21
  • [2] The management of cancer in the older adolescent
    Albritton, K
    Bleyer, WA
    [J]. EUROPEAN JOURNAL OF CANCER, 2003, 39 (18) : 2584 - 2599
  • [3] PATTERN OF CANCER IN MADINA-AL-MUNAWARA REGION
    ALSAIGH, AAAH
    ALLAM, MM
    KHAN, KA
    ALHAWSAWI, ZM
    [J]. ANNALS OF SAUDI MEDICINE, 1995, 15 (04) : 350 - 353
  • [4] Temporal trends in breast cancer presentation in the third world
    Anyanwu, Stanley N. C.
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2008, 27 (1)
  • [5] Epidemiology and prognosis of breast cancer in young women
    Assi, Hussein A.
    Khoury, Katia E.
    Dbouk, Haifa
    Khalil, Lana E.
    Mouhieddine, Tarek H.
    El Saghir, Nagi S.
    [J]. JOURNAL OF THORACIC DISEASE, 2013, 5 : S2 - S8
  • [6] Cancer in 15-to 29-year-olds by primary site
    Bleyer, Archie
    Viny, Aaron
    Barr, Ronald
    [J]. ONCOLOGIST, 2006, 11 (06) : 590 - 601
  • [7] Cancer in older adolescents and young adults: Epidemiology, diagnosis, treatment, survival, and importance of clinical trials
    Bleyer, WA
    [J]. MEDICAL AND PEDIATRIC ONCOLOGY, 2002, 38 (01): : 1 - 10
  • [8] Kaposi sarcoma trends in Uganda and Zimbabwe: A sustained decline in incidence?
    Chaabna, Karima
    Bray, Freddie
    Wabinga, Henry R.
    Chokunonga, Eric
    Borok, Margaret
    Vanhems, Philippe
    Forman, David
    Soerjomataram, Isabelle
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2013, 133 (05) : 1197 - 1203
  • [9] Adolescent and Young Adult Oncology
    Coccia, Peter F.
    Altman, Jessica
    Bhatia, Smita
    Borinstein, Scott C.
    Flynn, Joseph
    George, Suzanne
    Goldsby, Robert
    Hayashi, Robert
    Huang, Mary S.
    Johnson, Rebecca H.
    Beaupin, Lynda Kwon
    Link, Michael P.
    Oeffinger, Kevin C.
    Orr, Kathleen M.
    Pappo, Alberto S.
    Reed, Damon
    Spraker, Holly L.
    Thomas, Deborah A.
    von Mehren, Margaret
    Wechsler, Daniel S.
    Whelan, Kimberly F.
    Zebrack, Bradley J.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2012, 10 (09): : 1112 - 1150
  • [10] Fernandez Conrad V, 2006, Paediatr Child Health, V11, P103